[Problems in the clinical evaluation of chemotherapy for hormonally-unresponsive carcinoma of the prostate].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004351:Drug Resistance; D004967:Estrogens / Q000494:pharmacology; D006801:Humans; D007261:Infusions, Intra-Arterial; D007263:Infusions, Parenteral; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D004967:Estrogens; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin